Uri Greenbaum

711 total citations
26 papers, 232 citations indexed

About

Uri Greenbaum is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Uri Greenbaum has authored 26 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Genetics and 10 papers in Hematology. Recurrent topics in Uri Greenbaum's work include Acute Myeloid Leukemia Research (7 papers), CAR-T cell therapy research (7 papers) and Hemoglobinopathies and Related Disorders (5 papers). Uri Greenbaum is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), CAR-T cell therapy research (7 papers) and Hemoglobinopathies and Related Disorders (5 papers). Uri Greenbaum collaborates with scholars based in Israel, United States and Germany. Uri Greenbaum's co-authors include Partow Kebriaei, Elizabeth J. Shpall, Samer A. Srour, Neeraj Saini, Kris M. Mahadeo, Assaf Rudich, Sharon Etzion, Nava Bashan, R. Potashnik and David S. Hong and has published in prestigious journals such as Blood, Frontiers in Immunology and Mayo Clinic Proceedings.

In The Last Decade

Uri Greenbaum

24 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uri Greenbaum Israel	9	117	55	37	37	37	26	232
Zhengzheng Fu China	10	85 0.7×	55 1.0×	43 1.2×	27 0.7×	164 4.4×	41	269
Robert Offner Germany	9	49 0.4×	54 1.0×	85 2.3×	44 1.2×	43 1.2×	25	270
Michael Bär United States	8	66 0.6×	38 0.7×	54 1.5×	29 0.8×	48 1.3×	20	246
Gaëlle Fossard France	7	52 0.4×	23 0.4×	41 1.1×	38 1.0×	53 1.4×	23	194
Noa G. Holtzman United States	8	148 1.3×	47 0.9×	45 1.2×	34 0.9×	96 2.6×	51	273
Joshua Casan Australia	6	38 0.3×	33 0.6×	84 2.3×	24 0.6×	22 0.6×	17	253
Yueping Jia China	9	90 0.8×	45 0.8×	28 0.8×	32 0.9×	146 3.9×	34	243
Lamis Eldjerou United States	10	178 1.5×	55 1.0×	29 0.8×	28 0.8×	65 1.8×	22	260
L. Bergmann Germany	6	83 0.7×	52 0.9×	46 1.2×	45 1.2×	215 5.8×	21	322

Countries citing papers authored by Uri Greenbaum

Since Specialization

Citations

This map shows the geographic impact of Uri Greenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Greenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Greenbaum more than expected).

Fields of papers citing papers by Uri Greenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Greenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Greenbaum. The network helps show where Uri Greenbaum may publish in the future.

Co-authorship network of co-authors of Uri Greenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Greenbaum. A scholar is included among the top collaborators of Uri Greenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Greenbaum. Uri Greenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beyar‐Katz, Ofrat, Chava Perry, Efrat Luttwak, et al.. (2023). Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study. European Journal Of Haematology. 111(1). 63–71. 4 indexed citations

Merkel, Drorit, Shelly Soffer, Kalman Filanovsky, et al.. (2023). The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group. Acta Haematologica. 147(4). 427–434. 3 indexed citations

Yalniz, Fevzi, Uri Greenbaum, Oren Pasvolsky, et al.. (2023). Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation. Transplantation and Cellular Therapy. 30(2). 205.e1–205.e12. 2 indexed citations

Zou, Jun, Piyanuch Kongtim, Samer A. Srour, et al.. (2022). Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy. Frontiers in Immunology. 13. 1033871–1033871. 9 indexed citations

Saliba, Rima M., Uri Greenbaum, Qing Ma, et al.. (2021). Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation. Blood Advances. 5(17). 3407–3417. 5 indexed citations

Zou, Jun, Piyanuch Kongtim, Betül Oran, et al.. (2021). Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation. Haematologica. 107(4). 844–856. 3 indexed citations

Kamal, Mona, Jacinth Joseph, Uri Greenbaum, et al.. (2021). Patient-Reported Outcomes for Cancer Patients with Hematological Malignancies Undergoing Chimeric Antigen Receptor T Cell Therapy: A Systematic Review. Transplantation and Cellular Therapy. 27(5). 390.e1–390.e7. 28 indexed citations

Joffe, Erel, Uri Greenbaum, Kalman Filanovsky, et al.. (2020). Kinetics of pre‐myelodysplastic syndromes blood values correlate with disease risk and survival. Hematological Oncology. 38(5). 782–791. 1 indexed citations

Greenbaum, Uri, Fevzi Yalniz, Samer A. Srour, et al.. (2020). Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?. Biology of Blood and Marrow Transplantation. 26(10). 1759–1769. 7 indexed citations

10.

Greenbaum, Uri, Kris M. Mahadeo, Partow Kebriaei, Elizabeth J. Shpall, & Neeraj Saini. (2020). Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions. Frontiers in Oncology. 10. 1594–1594. 39 indexed citations

11.

Levi, Itai, Ohad Etzion, Alexander Fich, et al.. (2020). Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study. European Journal of Gastroenterology & Hepatology. 32(5). 569–574. 2 indexed citations

12.

Greenbaum, Uri, Partow Kebriaei, Samer A. Srour, et al.. (2020). Chimeric antigen receptor T‐cell therapy toxicities. British Journal of Clinical Pharmacology. 87(6). 2414–2424. 20 indexed citations

13.

Tadmor, Tamar, Ilana Levy, Yair Herishanu, et al.. (2019). Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia. Leukemia Research. 82. 24–28. 2 indexed citations

14.

Greenbaum, Uri, Erel Joffe, Kalman Filanovsky, et al.. (2018). Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?. European Journal Of Haematology. 101(4). 502–507. 8 indexed citations

15.

Joffe, Erel, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials. European Journal Of Haematology. 101(3). 399–406. 5 indexed citations

16.

Herishanu, Yair, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel. Anticancer Research. 38(11). 6423–6429. 8 indexed citations

17.

Oster, Howard S., Erel Joffe, Ilya Kirgner, et al.. (2018). Is bone marrow examination always necessary to establish the diagnosis of myelodysplastic syndromes? A proposed non-invasive diagnostic model. Leukemia & lymphoma. 59(9). 2227–2232. 3 indexed citations

18.

Joffe, Erel, Osnat Bairey, Riva Fineman, et al.. (2017). Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival. Hematological Oncology. 36(1). 128–135. 3 indexed citations

19.

Kalchiem‐Dekel, Or & Uri Greenbaum. (2015). Extramedullary Hematopoiesis in β-Thalassemia. Mayo Clinic Proceedings. 90(11). 1591–1592. 4 indexed citations

20.

Ben-Romano, Ronit, Assaf Rudich, Sharon Etzion, et al.. (2006). Nelfinavir Induces Adipocyte Insulin Resistance through the Induction of Oxidative Stress: Differential Protective Effect of Antioxidant Agents. Antiviral Therapy. 11(8). 1051–1060. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact